Lilly has submitted orforglipron to the FDA for the treatment of obesity, but Canadian regulatory submission status hasnt been publicly confirmed
When to Consider Restarting Semaglutide After Stopping If you experience rapid, unmanageable weight regain or return of binge-eating behaviors within 3-6 months of stopping, restarting compounded semaglutide may be appropriate
Learn about the interactions between certain supplements and atorvastatin (Lipitor), rosuvastatin (Crestor), and other cholesterol-lowering statins
Elashoff (79) also suggested that, compared with other common hypoglycemic drugs, GLP-1RA may increase the risk of chronic pancreatitis and then change the levels of cellular inflammatory factors and reactive oxygen species, thus increasing the risk of pancreatic cancer
For type 2 diabetes patients, retatrutide and a handful of other medications have reduced HbA1c by up to 2.4%